PPT-Dengue Vaccine: Dengvaxia

TM The scientific issues to practical issues รศดรพญเพณณนาท โอเบอรดอรเฟอร หวหนาหนวยโรคตดเชอ ภาคกมารเวชศาสตร. Lyle R. Petersen, MD, MPH. Brad Biggerstaff, PhD. Division of Vector-Borne Diseases. Centers for Disease Control and Prevention. Blood Products Advisory Committee Meeting. December 14, 2010. Agenda. Arbovirus risk model. virulence. Should we expect dengue virulence evolution in response to . Dengvaxia. ® . vaccination?. April 20, 2017. IDM Symposium, Bellevue, WA. Katia Koelle. Department . of . Biology. Duke University. Camille Sana. MPH Student. Walden University. PUBH 6165-4 :Environmental Health. Dr. Howard Rubin. February 2012. Source: Centers for Disease Control and Prevention . Goals/Objectives. Audience. . Malorie Schuler. Objectives. Describe the clinical manifestations of dengue fever.. Explore the prevention and treatments of dengue fever.. Observe the local implications of dengue fever in the Costa Rican population.. aedes. . aegypti. . http://www.bupa.co.uk/individuals/health-information/directory/d/dengue-fever. Dengue . occurs throughout much of the tropical world. Dengue became a world wide problem in the 1950’s though it rarely affects the US. . Part 1: . Overview of Dengue. What Is Dengue?. Prevalence of Dengue in Latin America. Dengue Reported Cases in the Americas, 2016 . to 2017. Dengue Serotypes. Limitations of Dengue Surveillance. Dengue Pathophysiology and Disease Severity. Stephen Jun Villejo | Paolo Redondo. Angela . Nalica. | . Erniel. Barrios. School of Statistics, UP . Diliman. Climate change and dengue. According to the World Health Organization, climate change affects occurrence of infectious diseases, apart from rapid demographic, environmental, social, technological and other changes.. Se diagnosticaron 1.950 casos probables, de los cuales 05 fueron dengue grave (0,3%), con una razón fiebre dengue/dengue grave de 389:1. El acumulado del año es de 41.938 casos, de los cuales 1,2% son dengue grave (499 casos), con una razón fiebre dengue/dengue grave de 83:1.. JAKARTA (CAPITAL CITY OF INDONESIA). DENGUE CASES IN INDONESIA. DENGUE CASES IN INDONESIA. Antiviral to dengue VIRUS (DENV). Antiviral to dengue VIRUS (DENV). ANIMAL MODEL. TITER OF DENV FROM MICE SERA. Foysal Ahammad. 1. , . Fazia Adyani Ahmad Fuad. 1,. *. 1. Department of Biotechnology Engineering, International Islamic University Malaysia, Kuala Lumpur 50728, Malaysia.. *. Corresponding author: fazia_adyani@iium.edu.my. . . . Dr. AMRIT YOG DATLEY . SOURCE : WHO guidelines for diagnosis, . . treatment, prevention and control. EPIDEMIOLOGY. Dengue is most rapidly spreading mosquito-borne viral disease.. the most common disease spread by insects. The virus is transmitted by bites from infected TRAVEL HEALTHMarch 2015 Page 1 of 2 What You do if You Suspect Dengue symptoms within 1 to 2 area where den 0 er: Health Emergency Supply N ot e UNICEF Supply Division February 2018 1 Dengue Feve r - Health Emergency Supply Note February 2018 1. Summary UNICEF provides a list of available supplies for t Ooi E, Goh K, Gubler DJ. Dengue Prevention and 35 Years of Vector Control in Singapore. Emerg Infect Dis. 2006;12(6):887-893. https://doi.org/10.3201/eid1206.051210.